Autoreactive monoclonal antibodies from patients with primary biliary cholangitis recognize environmental xenobiotics
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
A major problem in autoimmunity has been identification of the earliest events that lead to breach of tolerance. Although there have been major advances in dissecting effector pathways and the multilineage immune responses to mitochondrial self‐antigens in primary biliary cholangitis, the critical links between environmental factors and tolerance remain elusive. We hypothesized that environmental xenobiotic modification of the E2 subunit of the pyruvate dehydrogenase (PDC‐E2) inner lipoyl domain can lead to loss of tolerance to genetically susceptible hosts. Previously we demonstrated that serum anti‐PDC‐E2 autoantibodies cross‐react with the chemical xenobiotics 2‐octynoic acid and 6,8‐bis (acetylthio) octanoic acid and further that there is a high frequency of PDC‐E2‐specific peripheral plasmablasts. Herein we generated 104 recombinant monoclonal antibodies (mAbs) based on paired heavy‐chain and light‐chain variable regions of individual plasmablasts derived from primary biliary cholangitis patients. We identified 32 mAbs reactive with native PDC‐E2, including 20 specific for PDC‐E2 and 12 cross‐reactive with both PDC‐E2 and 2‐octynoic acid and 6,8‐bis (acetylthio) octanoic acid. A lower frequency of replacement somatic hypermutations, indicating a lower level of affinity maturation, was observed in the complementarity‐determining regions of the cross‐reactive mAbs in comparison to mAbs exclusively recognizing PDC‐E2 or those for irrelevant antigens. In particular, when the highly mutated heavy‐chain gene of a cross‐reactive mAb was reverted to the germline sequence, the PDC‐E2 reactivity was reduced dramatically, whereas the xenobiotic reactivity was retained. Importantly, cross‐reactive mAbs also recognized lipoic acid, a mitochondrial fatty acid that is covalently bound to PDC‐E2. Conclusion: Our data reflect that chemically modified lipoic acid or lipoic acid itself, through molecular mimicry, is the initial target that leads to the development of primary biliary cholangitis. (H epatology 2017;66:885–895)
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sirtuin 4 is a lipoamidase regulating pyruvate dehydrogenase complex activity
Mathias, R. A., Greco, T. M., Oberstein, A., Budayeva, H. G., Chakrabarti, R., Rowland, E. A., Kang, Y., Shenk, T., & Cristea, I. M. (2014) · Cell · doi:10.1016/j.cell.2014.11.046 · Cited by 430 · cited 7×
“V) in CDR1 did not affect the reactivity to PDC-E2.”
BackgroundInfluentialAmano, K., Leung, P. S. C., Rieger, R., Quan, C., Wang, X., Marik, J., Suen, Y. F., Kurth, M. J., Nantz, M. H., Ansari, A. A., et al. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.9.5874 · Cited by 187 · cited 2×
“SAc is a modified form of LA in which both sulfur atoms of the disulfide bond of the lipoyl ring are modified by acetyl groups, thereby maintaining PDC-E2 in a reduced state by preventing disulfide bond formation.((18,27-29)) Our study demonstrates that a subpopulation of anti-PDC-E2 autoantibodies, encoded with fewer…”
BackgroundSelf-citationOertelt, S., Rieger, R., Selmi, C., Invernizzi, P., Ansari, A. A., Coppel, R. L., Podda, M., Leung, P. S. C., & Gershwin, E. M. (2007) · Hepatology · doi:10.1002/hep.21583 · Cited by 168
Self-citationThe diagnosis of primary biliary cirrhosis
Bowlus, C. L., & Gershwin, M. E. (2014) · Autoimmunity Reviews · doi:10.1016/j.autrev.2014.01.041 · Cited by 162
Self-citationMoteki, S., Leung, P. S., Coppel, R. L., Dickson, E. R., Kaplan, M. M., Munoz, S., & Gershwin, M. E. (1996) · Hepatology · doi:10.1002/hep.510240117 · Cited by 152 · cited 10×
“IgA anti-PDC-E2 antibodies have been detected not only in serum but also in bile, saliva, and urine; and the presence of IgA anti-PDC-E2 in serum and in saliva has been associated with histological progression of PBC.(30-32) Biliary epithelial cells have the capacity to export dimeric IgA to the bile through polymeric…”
BackgroundSelf-citationMoteki, S., Leung, P. S., Dickson, E. R., Van Thiel, D. H., Galperin, C., Buch, T., Alarcon-Segovia, D., Kershenobich, D., Kawano, K., Coppel, R. L., et al. (1996) · Hepatology · doi:10.1002/hep.510230307 · Cited by 133
Self-citationLiu, H., Norman, G. L., Shums, Z., Worman, H. J., Krawitt, E. L., Bizzaro, N., Vergani, D., Bogdanos, D. P., Dalekos, G. N., Milkiewicz, P., et al. (2010) · Journal of Autoimmunity · doi:10.1016/j.jaut.2010.09.005 · Cited by 130 · cited 10×
“IgA anti-PDC-E2 antibodies have been detected not only in serum but also in bile, saliva, and urine; and the presence of IgA anti-PDC-E2 in serum and in saliva has been associated with histological progression of PBC.(30-32) Biliary epithelial cells have the capacity to export dimeric IgA to the bile through polymeric…”
BackgroundSelf-citationEnvironmental Basis of Autoimmunity
Floreani, A., Leung, P. S. C., & Gershwin, M. E. (2016) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-015-8493-8 · Cited by 122 · cited 1×
“Epidemiological studies, clinical research, and animal model studies have pointed to a role of environmental agents in triggering autoimmunity.((15-17)) However, the precise contribution of these agents to disease development is unknown.”
BackgroundSelf-citationInterpreting serological tests in diagnosing autoimmune liver diseases
Invernizzi, P., Lleo, A., & Podda, M. (2007) · Seminars in Liver Disease · doi:10.1055/s-2007-979469 · Cited by 107
Chung, B. K., Guevel, B. T., Reynolds, G. M., Gupta Udatha, D. B. R. K., Henriksen, E. K. K., Stamataki, Z., Hirschfield, G. M., Karlsen, T. H., & Liaskou, E. (2017) · Journal of Autoimmunity · doi:10.1016/j.jaut.2016.10.003 · Cited by 57
Cited by
Lindor, K. D., Bowlus, C. L., Boyer, J., Levy, C., & Mayo, M. (2019) · Hepatology · doi:10.1002/hep.30145 · Cited by 913
Self-citationLleo, A., Wang, G.-Q., Gershwin, M. E., & Hirschfield, G. M. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31607-x · Cited by 253
Self-citationTerziroli Beretta-Piccoli, B., Mieli-Vergani, G., & Vergani, D. (2018) · Journal of Autoimmunity · doi:10.1016/j.jaut.2018.10.004 · Cited by 61
E. coli and the etiology of human PBC: Antimitochondrial antibodies and spreading determinants
Yang, Y., Choi, J., Chen, Y., Invernizzi, P., Yang, G., Zhang, W., Shao, T., Jordan, F., Nemeria, N. S., Coppel, R. L., et al. (2022) · Hepatology · doi:10.1002/hep.32172 · Cited by 44
Self-citation
Metadata
- Authors
- Tanaka, T., Zhang, W., Sun, Y., Shuai, Z., Chida, A. S., Kenny, T. P., Yang, G., Sanz, I., Ansari, A., Bowlus, C. L., Ippolito, G. C., Coppel, R. L., Okazaki, K., He, X., Leung, P. S. C., & Gershwin, M. E.
- Venue
- Hepatology
- Published
- 2017-07-20
- Volume
- 66
- Issue
- 3
- Pages
- 885-895
- ISSN
- 0270-9139 (ISSN-L)
- 1527-3350
- OpenAlex
- W2611558568
- Cited by
- 35
- References
- 10
- FWCI
- 3.54
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Autoreactive monoclonal antibodies from patients with primary biliary cholangitis recognize environmental xenobiotics. https://app.cochat.ai/papers/10.1002/hep.29245
- The paper
- Tanaka, T., Zhang, W., Sun, Y., Shuai, Z., Chida, A. S., Kenny, T. P., Yang, G., Sanz, I., Ansari, A., Bowlus, C. L., Ippolito, G. C., Coppel, R. L., Okazaki, K., He, X., Leung, P. S. C., & Gershwin, M. E. (2017). Autoreactive monoclonal antibodies from patients with primary biliary cholangitis recognize environmental xenobiotics. Hepatology. https://doi.org/10.1002/hep.29245
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.